ATE58537T1 - Verfahren zur herstellung von imidazopyridinen. - Google Patents

Verfahren zur herstellung von imidazopyridinen.

Info

Publication number
ATE58537T1
ATE58537T1 AT87401353T AT87401353T ATE58537T1 AT E58537 T1 ATE58537 T1 AT E58537T1 AT 87401353 T AT87401353 T AT 87401353T AT 87401353 T AT87401353 T AT 87401353T AT E58537 T1 ATE58537 T1 AT E58537T1
Authority
AT
Austria
Prior art keywords
imidazopyridines
preparation
Prior art date
Application number
AT87401353T
Other languages
English (en)
Inventor
Guy Rossey
David Long
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of ATE58537T1 publication Critical patent/ATE58537T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT87401353T 1986-06-27 1987-06-17 Verfahren zur herstellung von imidazopyridinen. ATE58537T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8609330A FR2600650B1 (fr) 1986-06-27 1986-06-27 Procede de preparation d'imidazopyridines et composes intermediaires
EP87401353A EP0251859B1 (de) 1986-06-27 1987-06-17 Verfahren zur Herstellung von Imidazopyridinen

Publications (1)

Publication Number Publication Date
ATE58537T1 true ATE58537T1 (de) 1990-12-15

Family

ID=9336785

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87401353T ATE58537T1 (de) 1986-06-27 1987-06-17 Verfahren zur herstellung von imidazopyridinen.

Country Status (21)

Country Link
US (1) US4794185A (de)
EP (1) EP0251859B1 (de)
JP (1) JPH0653740B2 (de)
KR (1) KR940006594B1 (de)
AR (1) AR243188A1 (de)
AT (1) ATE58537T1 (de)
AU (1) AU7477287A (de)
CA (1) CA1324138C (de)
DE (1) DE3766300D1 (de)
DK (1) DK169505B1 (de)
ES (1) ES2019646B3 (de)
FI (1) FI872850A7 (de)
FR (1) FR2600650B1 (de)
GR (1) GR3001118T3 (de)
HU (1) HU204826B (de)
IE (1) IE60467B1 (de)
IL (1) IL82982A (de)
NO (1) NO167392C (de)
NZ (1) NZ220853A (de)
PT (1) PT85188B (de)
ZA (1) ZA874643B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2032455T3 (es) * 1986-01-22 1993-02-16 Synthelabo Procedimiento para preparar derivados de 3-acilaminometil-imidazo (-1,2-a)piridinas.
FR2615513B1 (fr) * 1987-05-21 1989-07-13 Synthelabo Derives d'acylaminomethyl-3 tetrahydro-5,6,7,8 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
DE69910795T2 (de) 1998-06-09 2004-06-17 Takeda Chemical Industries, Ltd. Pharmazeutische kombination mit einer trizyclischen verbindung und mindestens einer von zolpidem, zopiclone und brotizolam, zur behandlung oder verhinderung von schlafstörungen
ES2151834B1 (es) * 1998-08-06 2001-08-16 Sint Quimica Sa Procedimiento para preparar n,n,6-trimetil-2-(4-metilfenil)-imidazo-(1,2-a)-piridina-3-acetamida y sus sales.
EP1038875B1 (de) 1999-03-25 2003-06-04 Synthon B.V. Imidazopyridinderivate und Verfahren zu ihrer Herstellung
DE60020814T2 (de) * 1999-03-25 2006-05-04 Synthon B.V. Zolpidem salze
US6333345B1 (en) * 1999-05-14 2001-12-25 Sepracor, Inc. Methods of using and compositions comprising N-desmethylzolpidem
US6399621B1 (en) 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US20030091632A1 (en) * 1999-08-26 2003-05-15 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
EP1272181A2 (de) * 2000-04-13 2003-01-08 Synthon B.V. Arzneizubereitungen mit gesteuerter wirkstoffabgabe enthaltend ein hypnotikum
EP1473036B1 (de) * 2000-04-24 2006-08-09 Teva Pharmaceutical Industries Ltd. Zolpidem Hemitartrat Solvat
PL358548A1 (en) * 2000-04-24 2004-08-09 Teva Pharmaceutical Industries Ltd. Zolpidem hemitartrate
IT1318624B1 (it) 2000-07-14 2003-08-27 Dinamite Dipharma S P A In For Processo per la preparazione di 2-fenil-imidazo (1,2-a)piridin-3-acetammidi.
WO2002014306A1 (en) * 2000-08-17 2002-02-21 Cilag Ag Process for the preparation of imidazopyridines
US6596731B2 (en) 2001-03-27 2003-07-22 Hoffmann-La Roche Inc. Substituted imidazo[1,2-A] pyridine derivatives
US20020183522A1 (en) 2001-05-03 2002-12-05 Markus Sauter Process for preparing zolpidem
DE10121638A1 (de) * 2001-05-03 2002-11-14 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Imidazopyridinen
WO2004007496A1 (en) * 2002-07-15 2004-01-22 Scinopharm Taiwan, Ltd. Process for the preparation of imidazo(1,2-a)pyridine-3-acetamides
ES2320758T3 (es) 2002-12-18 2009-05-28 Mallinckrodt Inc. Sintesis de heteroaril acetamidas.
US20040241100A1 (en) * 2003-03-17 2004-12-02 Fabre Kramer Pharmaceutical, Inc. Nasally administrable compositions of zolpidem and methods of use
GB0311457D0 (en) * 2003-05-19 2003-06-25 Sciencom Ltd New therapeutic use
WO2005060968A1 (en) 2003-12-11 2005-07-07 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
ATE451371T1 (de) * 2004-06-22 2009-12-15 Mallinckrodt Inc Synthese von heteroarylacetamiden aus reaktionsmischungen mit reduziertem wassergehalt
WO2006008636A2 (en) * 2004-07-16 2006-01-26 Ranbaxy Laboratories Limited Processes for the preparation of zolpidem and its hemitartrate
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
WO2007040995A1 (en) * 2005-10-03 2007-04-12 Mallinckrodt Inc. Process for preparing zolpidem hemitartrate and tartrate polymorphs
CA2626242A1 (en) * 2005-10-17 2007-04-26 Mallinckrodt Inc. Polymorph transformation of zolpidem in tablet matrix
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
DE602006008339D1 (en) 2005-11-18 2009-09-17 Synhton B V Zolpidemtabletten
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (de) * 2006-09-08 2009-06-17 Braincells, Inc. Kombinationen mit einem 4-acylaminopyridin-derivat
US20080145425A1 (en) * 2006-12-15 2008-06-19 Pliva Research & Development Limited Pharmaceutical composition of zolpidem
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
CN103360387B (zh) * 2012-03-28 2016-12-14 江苏豪森药业集团有限公司 一种制备化合物唑吡坦的方法
KR101704589B1 (ko) * 2016-07-12 2017-02-08 주식회사 뉴트라팜텍 후박 추출물 및 신이 추출물의 혼합물을 유효성분으로 함유하는 치주조직 성장 촉진용 및 치주염 예방 또는 치료용 약학적 조성물
CN107793415A (zh) * 2016-12-01 2018-03-13 湖南省食品药品检验研究院 酒石酸唑吡坦杂质的合成方法
CN106749237A (zh) * 2016-12-28 2017-05-31 江苏豪森药业集团有限公司 酒石酸唑吡坦及其中间体的制备方法
CN114057725B (zh) * 2020-07-31 2024-01-16 株洲千金药业股份有限公司 一种酒石酸唑吡坦的合成方法
CN114057727B (zh) * 2020-07-31 2024-02-27 株洲千金药业股份有限公司 一种唑吡坦中间体的合成方法
CN114057726A (zh) * 2020-07-31 2022-02-18 株洲千金药业股份有限公司 一种唑吡坦盐酸盐的合成方法
CN114249668B (zh) * 2020-09-25 2024-08-23 鲁南制药集团股份有限公司 一种唑吡坦中间体n,n-二甲基-2-氧乙酰胺的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR68765B (de) * 1979-06-20 1982-02-17 Rohm & Haas
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
NZ220853A (en) 1989-09-27
GR3001118T3 (en) 1992-05-12
IL82982A0 (en) 1987-12-20
FI872850A7 (fi) 1987-12-28
IL82982A (en) 1992-03-29
IE871723L (en) 1987-12-27
EP0251859A2 (de) 1988-01-07
HUT44547A (en) 1988-03-28
CA1324138C (en) 1993-11-09
NO167392B (no) 1991-07-22
EP0251859A3 (en) 1989-07-19
DK328187A (da) 1987-12-28
PT85188B (pt) 1990-03-30
KR880000433A (ko) 1988-03-25
US4794185A (en) 1988-12-27
AR243188A1 (es) 1993-07-30
NO872682L (no) 1987-12-28
NO167392C (no) 1991-10-30
ZA874643B (en) 1988-02-24
DK169505B1 (da) 1994-11-14
HU204826B (en) 1992-02-28
DK328187D0 (da) 1987-06-26
FR2600650B1 (fr) 1988-09-09
PT85188A (fr) 1987-07-01
FR2600650A1 (fr) 1987-12-31
DE3766300D1 (de) 1991-01-03
EP0251859B1 (de) 1990-11-22
AU7477287A (en) 1988-01-07
IE60467B1 (en) 1994-07-13
ES2019646B3 (es) 1991-07-01
JPH0653740B2 (ja) 1994-07-20
FI872850A0 (fi) 1987-06-26
JPS638384A (ja) 1988-01-14
KR940006594B1 (ko) 1994-07-23
NO872682D0 (no) 1987-06-26

Similar Documents

Publication Publication Date Title
DE3852381D1 (de) Verfahren zur Herstellung von para-Ethylphenol.
DE3766300D1 (de) Verfahren zur herstellung von imidazopyridinen.
DE3888647D1 (de) Verfahren zur Herstellung von Aminopropylsilanen.
ATE42273T1 (de) Verfahren zur herstellung von (z)-1-phenyl-1diethylaminocarbonyl-2-aminomethyl-cyclopropanhydrochlorid.
DE3889595D1 (de) Verfahren zur Herstellung von Arylpiperidincarbinolen.
DE3750501D1 (de) Verfahren zur Herstellung von Pyrimidinen.
DE68913447D1 (de) Verfahren zur Herstellung von Halofluorbenzolen.
DE3789412D1 (de) Verfahren zur Herstellung von 3-Alkoxymethylcephalosporinen.
ATE59634T1 (de) Verfahren zur herstellung von dialkyldisulfiden.
DE3885262D1 (de) Verfahren zur Herstellung von 2-Chlor-5-methyl-pyridin.
DE3787929D1 (de) Verfahren zur Herstellung von 1-Aminoanthrachinon.
DE3850177D1 (de) Verfahren zur Herstellung von tertiären Alkyldimethylhalosilanen.
DE3886877D1 (de) Verfahren zur Herstellung von Triphendioxazinen.
DE3751186D1 (de) Verfahren zur Herstellung von modifizierten Polycycloolefinen.
DE3852408D1 (de) Verfahren zur Herstellung von Acyloxialkansulfonaten.
DE58905664D1 (de) Verfahren zur Herstellung von N-Hydroxypyrazolen.
DE58905592D1 (de) Verfahren zur Herstellung von N-Hydroxypyrazolen.
DE58907097D1 (de) Verfahren zur Herstellung von 4-Chlorpyrazolen.
DE68920298D1 (de) Verfahren zur Herstellung von 4-Acetoxyazetidinonen.
DE3689174D1 (de) Verfahren zur Herstellung von Riboflavin.
DE3883919D1 (de) Verfahren zur Herstellung von o-Nitrophenetol.
DE68919584D1 (de) Verfahren zur Herstellung von Chlorfluorbenzolen.
DE3883433D1 (de) Verfahren zur Herstellung von Polybuten-1.
DE3851376D1 (de) Verfahren zur Herstellung von Triphendioxazinverbindungen.
DE68916375D1 (de) Verfahren zur Herstellung von 3-Iminonitrilen.